Abstract Purpose of Review The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA), have recently undergone testing for their ability to reduce …

The regular overconsumption of energy‐dense foods (rich in lipids and sugars) results in
elevated intestinal nutrient absorption and consequently excessive accumulation of lipids in …

There is currently growing attention being paid to the role of elevated triglycerides (TGs) as
important mediators of residual atherosclerotic cardiovascular disease (ASCVD) risk. This …

The role of omega-3 polyunsaturated fatty acids (PUFAs) in primary and secondary
prevention on major cardiovascular events (MCE) is inconclusive due to the potential …

Interest in omega-3 fatty acids (colloquially known as fish oils) to lower residual
cardiovascular risk in statin-treated patients has increased markedly in the wake of recent …

Despite cardiovascular disease (CVD) reductions with high-intensity statins, there remains
residual risk among patients with metabolic disorders. Alongside low-density lipoproteins …

N-acyl amino acids (NAAs) are amphiphilic molecules, with different potential fatty acid and
head group moieties. NAAs are the largest family of anandamide congener lipids discovered …

Managing atherosclerotic cardiovascular disease (ASCVD) often involves a combination of
lifestyle modifications and medications aiming to decrease the risk of cardiovascular …

Both cardiovascular disease (CVD) and cognitive decline are common features of aging.
One in 5 deaths is cardiac for both men and women in the United States, and an estimated …

Background Dietary astaxanthin (AST) exhibits the ability to resist lipid accumulation and
stimulate hepatic autophagy. Natural AST predominantly exists in stable esterified forms …